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Herpes zoster is the consequence of reactivation of latent varicella zoster virus from dorsal root ganglia.  Postherpetic 
neuralgia (PHN) may be diagnosed when pain persists in a dermatomal pattern long after the vesicular erruption 
has healed.  PHN is a kind of neuropathic pain.  The pathophysiology of PHN is uncertain, but neuropathic pain due 
to denervation supersensitivity may be important to understand the pathophysiology of PHN.  Numerous treatment 
have been introduced for the management of PHN, but no methods that results in complete remission.  Gunn's 
intramuscular stimulation (IMS) is one of the best treatment of chronic pain, especially neuropathic pain.  We tried 
Gunn's IMS for treatment of PHN patients affecting thoracic dermatomes.  As a result, the visual analogue scale (VAS) 
was decreased from 7-8 to 2-3 and the result were satisfactory.  The purpose of this case report is to introduce the 
Gunn's IMS and review our experience for the treatment of PHN.  (Korean J Anesthesiol 2010; 58: 311-317)
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    Varicella zoster occurs as a result of the infections with 
varicella-zoster virus, and it is latently present in the dorsal 
root ganglion of spinal cord. Then, it is re-activated due to the 
impaired or suppressed immune responses. In the skin areas 
where the corresponding nerves are innervated, it produces a 
unilateral, vesicular eruption. In addition to the skin symptoms, 
the pain is concurrently present at the site of invasion. Besides, 
the skin is not healed but can be progressed to postherpetic 
neuralgia (PHN). Postherpetic neuralgia (PHN) varicella zoster 
is a pain which is persistently present for more than 30 days 
following the onset of skin rash or for more than 3 months [1]. 
Infections with varicella zoster virus trigger the occurrence 
of inflammations in the skin tissue and then stimulate the 
sympathetic nervous system. Thus, they cause the decreased 
perfusion of carpillary vessels within the nerve fibers [2]. This 
decreased blood flow creates an ischemia. A persistent presence 
of the ischemia causes the degeneration of nerve transmission 
fibers. Owing to this, patients complain of persistent pain, 
allodynia or paresthesia. In severe cases, there might be such 
symptoms as depression, insomnia and decreased appetite. In 
these cases, there is a difficulty of maintaining the daily lives.
    Most cases of varicella zoster are healed without compli-312 www.ekja.org
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cations. In approximately 10% of total cases, however, the 
disease is progressed to neuralgia following varicella zoster. 
In elderly patients aged 60 years or older, those with diabetes 
mellitus or immunocompromised ones, the morbidity has been 
reported to be increased.
    It is an intractable disease for which there are no established 
treatment regimens. For the treatment, however, there are 
treatment methods such as drug therapy (anti-depressants 
or anti-convulsants) and local swabbing anesthetics or nerve 
block. In particular, epidural block or intercostal nerve block are 
advantageous in accurately treating the affected dermatomes. 
Therefore, these treatment regimens are frequently performed 
at many pain clinics.
    An injection for sensitized and chronic lesions (trigger point 
injection) or dry needling have been widely accepted as the 
effective treatment regimens for pain control. But Gunn further 
systematized these regimens and then considered the deep 
paravertebral muscles and the stimulation of vertebral joints 
to be important. Then, this was termed as deep dry needling or 
Gunn’s IMS. Based on these treatment regimens, interventional 
microadhesilolysis and nerve stimulation (IMNS) and 
fluoroscopy guided interventional musculoskeletal adhesiolysis 
and nerve stimulation (FIMS) have been developed to provide 
more invasive and powerful stimulations. These treatment 
modalities are effective for the treatment of hypersensitized 
neuropathy due to the damage of peripheral nerve, one of the 
mechanisms by which the chronic pain is generated. 
    Given the above background, we experienced good treatment 
outcomes using Gunn’s IMS treatment in a case of neuropathy 
following varicella zoster infections. Here, we report our case 
with a review of literatures.
Case Report
Case 1
    A 53-year-old female patient visited us with a chief complaint 
of sharp and burning pain developed in the right chest. Six 
months prior to outpatient visit, due to the presence of varicella 
zoster occurring in the 5
th and 6
th dermatome of the right chest, 
the patient visited department of dermatology. Then, the patient 
continually received the treatments using anti-viral agents, 
non-steroidal anti-inflammatory agents, anti-depressants 
and digestive drugs. Due to the persistent presence of pain, 
however, the patient was referred to a pain clinic of the current 
medical institution. On physical examination, in the 5
th and 6
th 
dermatomes of right chest areas, the patient presented with 
the aggravated nocturnal allodynia and hyperesthesia. In this 
patient, the visual analogue scale (VAS) was 7/10. The patient 
complained of severe pain. On baseline examination, there 
were no notable findings.
    For the treatment, a flexible needle which was specifically 
designed for IMS therapy, of 0.25 mm in thickness and 50 mm in 
length, was inserted in a plunger (Fig. 1). A needle was thin and 
easily flexible. Accordingly, it can minimize risks of developing 
the damage of vital blood vessels or nerve tissue. In the areas 
which were 1 cm lateral to the spinou process of the 6
th and 7
th 
thoracic vertebra, a needle was placed vertical to the skin until 
the bone contact was perceived. Then, a needle was rotated 
several times and thereby the multifidus muscle was stimulated. 
In the areas which were 3-4 cm lateral to the intervertebral 
space at such levels as T5-6, T6-7 and T7-8, to prevent the 
occurrence of pneumothorax, a needle was placed in a slanted 
manner at an angle of 15-20 degree from the vertical line to the 
vertebral directions. Then, a needle was rotated several times. 
Thus, the tissue around the vertebral facet was stimulated. T5-7 
thoracic dermatomes were stimulated (Fig. 2). During Gunn’s 
IMS therapy, no attempts of pharmacological injections have 
been made excluding a needle. Because a needle stimulation 
was sufficient for the tissue around the multifidus muscle 
originating from the spinous process and inserting in the caudal 
facet joint and the tissue around the posterior facet where the 
medial branch of primary dorsal ramus was distributed, as 
shown in medial branch block, without using such equipments 
as fluoroscopy or ultrasonography, the thoracic spinous process 
at the affected spinal segment was selected as an anatomical 
landmark. Then, without any complications, the surgery 
was successfully performed. During the first two weeks, the 
treatment was performed twice a week at a 3-day interval. 
During the following two weeks, the treatment was performed 
six times once a week for a total of four weeks.
    Four weeks following the treatment, VAS was improved from 
7 to 3 points. An examination was performed after two weeks, 
Fig. 1. This photograph shows that various length of IMS needles 
(Right) and types of plungers (Left).313 www.ekja.org
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and this showed that VAS was maintained at 3 points. Then, the 
treatment was completed.
Case 2
    A 66-year-old woman visited us with a chief complaint 
of intermittent pin-prick pain occurring in the right chest. 
During a 4-month period, due to the occurrence of neuralgia 
developed varicella zoster which occurred along the the 4
th 
thoracic dermatome, the patient underwent intermittent 
stellate ganglion block and intercostal nerve block at a local 
clinic. Meanwhile, the symptoms were not improved. Therefore, 
the patient was admitted to our medical institution. The patient 
stated that the symptoms were particularly worsened during 
the night, who were prescribed to take analgesics and anti-
depressants. Three weeks prior to outpatient visit, the patient 
deliberately discontinued the administration of drugs. On 
physical examination, the patient complained of allodynia and 
hyperesthesia where there was a concurrent presence of the 
scar tissue formed in the corresponding dermatomes. At the 
time of admission, VAS was 7-8/10 points. For the treatment, 
a needle was placed in the multifidus muscle at the level of T5 
and the tissue around the facet at the level of T5-6. Four weeks 
after the treatment, VAS was decreased from 7-8 points at 
the time of admission to 3 points. Two weeks later, according 
to an evaluation performed in an outpatient setting, VAS was 
improved to 2 points and this led to a closure of the treatment.
Case 3
    A 57-year-old man visited us with a chief complaint of 
stabbing pain occurring in the left chest. Four months prior to 
outpatient visit, due to the presentation of skin lesions and pain 
occurring in the left 7
th and 8
th thoracic vertebra, the patient was 
diagnosed with varicella zoster at department of dermatology 
and then received the drug treatments. But the pain was 
persistent present. At a local clinic, the patient was diagnosed 
with neuralgia following varicella zoster. Then, the patient 
received subcutaneous drug treatment and intercostal nerve 
block. Due to a lack of the improvement of symptoms, however, 
the patient was referred to us. On physical examination, in the 
left 7
th and 8
th thoracic dermatomes, there were allodynia and 
hyperesthesia. VAS was 7-8/10 points. For the treatment, a 
needle was placed in the thoracic 8
th and 9
th multifidus muscle 
and thoracic 7
th and 8
th, 8
th and 9
th and 9
th and 10
th tissue around 
the vertebral facet. Four weeks following the treatment, VAS 
was decreased from 7-8 point at the time of admission to 3 
points. An examination was performed two weeks later, and this 
showed that VAS was maintained at 2-3 points and this led to a 
closure of the treatment.
Case 4
    A 72-year-old man visited us with a chief complaint of 
intermittent intractable pain occurring in the right chest. 
On past history, the patient sustained a fracture of the left 
femur. At department of orthopedic surgery of our medical 
institution, the patient was hospitalized to take the surgery. 
At the time of admission, due to the presentation of varicella 
zoster and its resulting pain extensivly occurring along the 
right 6-8
th dermatomes, the patient received drug treatments 
at department of dermatology. During the hospitalization 
treatments, the symptoms were improved. Two months 
following the discharge, the patient complained of severe pain 
occurring in the corresponding dermatomes. Then, the patient 
visited department of dermatology and was referred to a pain 
clinic. On physical examination, the patient complained of 
allodynia, hyperesthesia and hyperalgesia where there was a 
Fig. 2. (A) This photograph shows 
that anatomic landmark when Gunn's 
IMS treatment has undergone to 
thoracic multifidi (5-8th). (B) This 
photograph shows that thoracic 
facet joints (5-7th) stimulation has 
undergone with plunger.314 www.ekja.org
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concurrent presence of the scar tissue formed in the right 6
th, 
7
th and 8
th dermatomes. Besides, the patient also complained 
of sleep disturbance. At the time of admission, VAS was 8/10 
points. On routine lab test, there were no notable findings that 
impede the treatments for diabetes mellitus, blood coaguation 
disorder and hemostasis abnormality. For the treatment, a 
needle was placed in the thoracic 8
th and 9
th multifidus muscle 
and thoracic 7
th and 8
th, 8
th and 9
th and 9
th and 10
th tissue around 
the vertebral facet. Four weeks following the treatment, VAS was 
decreased from 8 points at the time of admission to 2 points. An 
examination was performed two weeks later, and this showed 
that VAS was maintained at 2 points and this led to a closure of 
the treatment.
    In the above patients, the treatment period and frequency 
were four weeks and a total of six times. Based on the characte-
ristics of patients, the age, sex, disease duration, the pattern 
of pain and the affected dermatomes showed the different 
characteristics (Table 1). Following the treatment, VAS 
improvement rate (VAS improvement rate (%)= VAS prior 
to treatment - VAS during evaluation × 100 ) was almost 
consistent (Fig. 1). 
Discussion
    Neuralgia following varicella zoster is defined as the pain 
which is persistently present even following the treatment of 
skin lesions. In most cases, with the time progression or after 
one month, there is a tendency that neuralgia is decreased. Up 
to a period of 2-6 months, the disease duration is considered. 
Regarding the occurrence frequency, approximately 10% 
of patients with varicella zoster are progressed to PHN. In 
elderly patients, those with immunocompromised status or 
immunosuppressive patients, the morbidity has been reported 
to reach 20-50%. The affected dermatomes may be some 
part of body areas. Approxmately more than 50% of patients 
develop the lesions in the areas where the thoracic nerves are 
innervated. Then, in cases of cervical nerve innervation and 
cranial nerves, the lesions occur the most frequently in the first 
branch of cranial nerve III. In regard to the skin symptoms, the 
vesicles are formed with the beginning of rash formation. In the 
areas where the nerve was invaded, the pain is generated. The 
pain disappears while the skin symptoms are healed. In some 
cases, however, the lesions are progressed to PHN and these 
lesions are persistently present for several months or several 
years. It is commonly encountered that several symptoms 
which cannot be verbally expressed. The pain is persistently 
present and causes a torment. In most cases, it causes a sleep 
disturbance and the impaired daily lives. Little is known 
about its pathophysiology. Due to the re-activated varicella 
zoster virus, the inflammation within the nerve causes the 
nerve damage. This damage is spreaded to the spinal dorsal 
root, dorsal root ganglion, peripheral nerves, dorsal nerve 
root and spinal nerve. Then, it generates an abnormal ectopic 
electrical potential (peripheral pathogenesis). Following the 
nerve damage, the sympathetic nerve receptor is increased. In 
response to the sympathetic nerve stimulation, the sympathetic 
nerve is sensitively responded (abnormal connection 
mechanism). Due to the increased activity of nociceptor 
C-fiber, the excitability of spinal olfactory sensation was 
increased. Due to the generation of suppressive intermediate 
neurons, the suppressive mechanisms were impaired. Due to 
the structural reconstruction of olfactory sensation where the 
pain is generated due to the normal unharmful stimulations 
of major myelinated A-beta fibers, the central nervous system 
was desensitized. It has also theoretically been proposed that 
the isometric discharge of persistent peripheral nerve fibers 
triggers the occurrence of central sensitization where NMDA 
(N-methyl-D-aspartate) plays a major role and this leads to 
the persistent presence of pain [3-5]. All of these mechanisms 
are gradually considered to be a key mechanism which causes 
neuropathic pain. If the detrimental stimulations on the nerve 
should be terminated during a short-term period, the nerve 
would immediately make a recovery of the original function. 
In cases in which the neuralgia is persistently present as shown 
Table 1. Characteristics of Patients for Gunn's IMS
Case  No. Sex/Age Characteristics of pain Duration (months) Lesion of dermatome Treatment site
1
2
3
4
F/53
F/66
M/57
M/72
Sharp & burning
Pin-prick
Stabbing
Intermittent intractable
6 
4 
4 
2 
T5,6 (Rt.)
T4 (Rt.)
T7,8 (Lt.)
T6,7,8 (Rt.)
T6,7 multifidus
T5-6-7-8 FJ
T5 multifidus
T4-5-6 FJ
T8,9 multifidus
T7-8-9-10 FJ
T7,8,9 multifidus
T6-7-8-9-10 FJ
Gunn's IMS: Gunn's intramuscular stimulation, FJ: facet joints.315 www.ekja.org
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in neuralgia following varicella zoster infection, however, the 
impaired nerve function is persistently present. The sensitvity 
of peripheral receptors is increased. This may induce the 
occurrence of chronic pain, i.e., neuropathic pain [6].
    Nerve stimulation is one the representative treatment 
modalities for chronic pain. Exercise or physical therapy are 
a stimulatory effect via an exercise receptor. A hot pack or 
massage would have a stimulatory effect on the temperature 
or baroreceptor. A stimulatory effect of Gunn's IMS therapy 
induces the electrical damage potential due to a needle of 
biological tissue. Through a needle, it promotes the releases 
of chemomediators such as substance P, neurokinin A and 
tachykinin [7]. Various mechanisms have been used to explain 
and these mechanisms include the modulation of detrimental 
afferent information of the central nervous system, the 
suppression of intercalated cells due to the activation of opioid 
pain-reducing system, the changes of activity of each cell on 
the ventral side due to the mechanical, chemical and electrical 
stimulations or a loss of the denervating response due to a 
needle [8,9]. A stimulatory effect of a needle is maximized when 
it is close to the nerve root where there is an abundant amount 
of muscle spindle tissue and the damaged nerve root. The 
placement of a needle in the deep vertebral muscle, vertebral 
facet, if possible, or nerve root is the most effective. Following 
this, a rotation of the needle would further increase the release 
of chemical mediators as well as the damage current in the 
muscle spindle tissue or the tissue around the nerve.
    In the disease progression from varicella zoster to PHN, the 
duration extending from the age and rash formation to the 
initiation of treatment is the most responsible factor. According 
to Colding, only the sympathetic nerve block which was 
performed within two weeks following the onset of rash had 
a preventive effect on the progression to PHN. This author 
also noted that there was a lack of the effects of sympathetic 
nerve block in cases of PHN in which the age was increased 
or more than two months elapsed following the manifestation 
of symptoms [10]. According to Winnie, in the correlation 
between the time point of initiation of nerve block treatment 
and the treatment effect, the treatment prognosis is greatly 
affected by the age. Particularly in elderly patients, within two 
months prior to the occurrence of irreversible changes, the 
sympathetic nerve block is important and the treatment effect 
is good [11]. This implies that the time point for determining the 
treatment effect and the initiation of treatment. Accordingly, 
the use of active treatment in the early stage of varicella zoster 
infection prevents the progression to PHN. Therefore, this is 
utmost important. An early administration of anti-viral agents 
or sympathetic nerve block should be performed for preventive 
purposes. In the current cases, patients had an age range of 
50-70 years. It can therefore be stated that the age may affect 
the treatment prognosis. But individual patients receive the 
treatment without overlooking the symptoms. Besides, the 
current cases were all recurrences. Due to the delayed initiation 
of treatment, the morbidity of PHN was increased and this led 
to the decreased treatment effect, which have been reported by 
Colding and Winnie, and this was not in agreement with current 
cases. In the treatment of affected individuals, there are such 
treatment modalities as anti-depressants, anti-convulsants, 
opioids, local application, various types of nerve block, other 
acupunctures, TENS and surgical treatment (a local resection 
of the affected skin). For oral drug treatments, tricyclic anti-
depressants have been established as a standard treatment 
modality. But these drugs are prohibited for the treatment of 
cardiovascular diseases. That is, there are a substantial number 
of side effects that have been reported. Such anti-convulsants 
or opioids as carbamazepine have a greater degree of the side 
effects as compared with their effectiveness. A novel type of 
anti-convulsants, gabapentin has a lower profile of the toxicity 
and side effects and it has been used to treat neuropathic pain. 
Lee et al. [12] noted that gabapentin has an excellent profile 
of the treatment effect in patients with PHN. Such treatment 
modalities as astrocyte ganglion block, epidural nerve block, 
nerve root block and sympathetic nerve block are also effective 
treatment methods. In particular, epidural nerve block or 
intercostal nerve block are advantageous in treating the affected 
sites both accurately and easily. Therefore, they have frequently 
been used for the treatment. According to Lee et al., [13] keta-
mine has been reported to be effective for the treatment of 
hyper  sensitization of central nervous system as the antagonist 
for NMDA receptor and its intravenous injection or persistent 
subcutaneous injection were also effective for the treatment of 
neuralgia following varicella zoster. The treatment effect of a 
low-power laser therapy has also been reported. As described 
here, many drugs and various treatment modalities have been 
introduced. To such an extent, the incurability of this disease 
hase been indicated.
    According to Canon, through his literature “Canon’s law 
of denervation supersensitivity” , in cases in which a single 
factor was desensitized completely or incompletely from the 
functional chains of neurons, even if a series of factors which 
were damaged in the chain should not denervated by other 
nerves or there should be effects which nerve stimulation 
or inhibitory/excitatory chemical mediators can have, the 
hypersensitivity of receptors which are present in the areas 
where the corresponding nerve was innervated would appear. 
Besides, this author noted that this hypersensitivity was 
maximally present and it was dwindled to the terminal part. To 
put this in another way, if the nerve should be damaged, the 
hypersensitivity of receptors which are present in all the areas 
where the nerve was innervated under the areas where the nerve 316 www.ekja.org
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damage occurred. This implies not only the hypersensitivity of 
pain receptors but also that of receptors which are responsive 
to all the chemical mediators. This phenomenon can induce 
the abnormal nerve functions even in the absence of marked 
nerve damage. Due to this abnormal nerve function, the 
hypersensitivity of receptors in the innveration unit occurs. 
This is a cause of chronic pain or deeply associated with it [14]. 
According to Gunn, a great number of various types of pain 
syndrome where there is grossly a lack of the causal relationship 
might be associated with the development of system which was 
generated in the denervation supersensitivity, hypersensitive 
receptors or individual nerve system. In other words, due 
to the nerve damage, if a specific nerve should fall short of 
the reference and should not appropriately function, i.e., 
the status of neuropathy, the corresponding nerve would be 
hypersensitive or malfunctioned.
    A neuropathic pain is referred to a pain which was developed 
even in the absence of permanent tissue injury or inflammatory 
findings and then persistently present. Although the causative 
stimulations cannot be identified, the response was induced 
and then persistently present. Eventually for any reasons, if the 
nerve damage should occur, the nerve would be hypersensitive. 
A neuropathic pain due to the hypersensitivity following the 
nerve block has focused on the hypersensitivity of structures 
which were present in the areas where the damaged nerve was 
innervated. Using the resolution of this hypersensitivity, the 
results of pain alleviation could be sufficiently obtained.
    The areas where Gunn's IMS therapy could be performed 
representatively include cases in which there was a neuropathic 
pain due to the hypersensitivity following the nerve block. A 
stimulatory effect of dry needle which is used for interventional 
nerve stimulation therapy generates the tissue damage and 
current of injury. Then, it releases healing soruce of bio-energy 
and then causes the local hemorrhage. Thus, it induces the 
synthesis of growth factor originated from plateletspromoting 
the wound healing. Besides, it stimulates A-delta fiber and 
olfactory cells in the white matter of spinal cord. Thus, these 
cells secrete enkephaline and this leads to the suppression of 
cells forming substantia gelatinosa. Following this, it blocks 
the stimulation transferring pathway by which the stimulation 
is transferred to wide dynamic range (WDR) cells in C-fiber 
which is involved in the chronic pain. Through this effect, the 
hypersensitivity of nerve block is decreased or removed. Thus, a 
neuropathic pain is healed [7,8]. 
    We have speculated that the pathogenesis and etiology of pain 
in patients with PHN are associated with the hypersensitivity 
of nerve block. As the most effective treatment method for 
desensitizing the hypersensitivity, Gunn's IMS therapy was used 
and the alleviation of symptoms was expected. We performed 
Gunn's IMS therapy 1-2 times a week a total of six times in 
four patients with PHN who visited us with a chief complaint of 
chest pain. For surgical sites, thoracic multifidus muscle and the 
tissue around the joint were selected. In regard to the treatment 
effect, VAS scores were decreased from 7-8 points at the time 
of outpatient visit to 2-3 points at the completion of treatment. 
These results indicate that the pain was decreased and the 
symptoms were improved. The final improvement rate of VAS 
was 68% on average and this corresponded to satisfactory 
treatment outcomes (Table 2).
    Given the above background, in patients with PHN who 
were refractory to the previous drug treatment and nerve 
block therapy, we assumed that Gunn's IMS therapy or its 
concomitant use with previous treatment regimens are 
recommendable. With the application of Gunn's IMS therapy 
to the treatment of patients with PHN, we obtained satisfactory 
treatment outcomes. Here, we report our case with a review of 
literatures.
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